Authors: KEHNE JH KANE JM CHANEY SF HURST G MCCLOSKEY TC PETTY MA SENYAH Y WOLF HH ZOBRIST R WHITE HS

Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES, Epilepsy research, 27(1), 1997, pp. 41-54

Authors: BARON BM HARRISON BL KEHNE JH SCHMIDT CJ VANGIERSBERGEN PLM WHITE HS SIEGEL BW SENYAH Y MCCLOSKEY TC FADAYEL GM TAYLOR VL MURAWSKY MK NYCE P SALITURO FG

Citation: Bm. Baron et al., PHARMACOLOGICAL CHARACTERIZATION OF MDL-105,519, AN NMDA RECEPTOR GLYCINE SITE ANTAGONIST, European journal of pharmacology, 323(2-3), 1997, pp. 181-192

Authors: KEHNE JH BARON BM CARR AA CHANEY SF ELANDS J FELDMAN DJ FRANK RA VANGIERSBERGEN PLM MCCLOSKEY TC JOHNSON MP MCCARTY DR POIROT M SENYAH Y SIEGEL BW WIDMAIER C

Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981

Authors: KANE JM STAEGER MA DALTON CR MILLER FP DUDLEY MW OGDEN AML KEHNE JH KETTELER HJ MCCLOSKEY TC SENYAH Y CHMIELEWSKI PA MILLER JA

Citation: Jm. Kane et al., 5-ARYL-3-(ALKYLTHIO)-4H-1,2,4-TRIAZOLES AS SELECTIVE ANTAGONISTS OF STRYCHNINE-INDUCED CONVULSIONS AND POTENTIAL ANTISPASTIC AGENTS, Journal of medicinal chemistry, 37(1), 1994, pp. 125-132